← All drugs Report issue

atengenal

Small moleculeexperimental

Clinical trial activity

18 trials · 1 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

18

Phase 3

2

Phase 4

0

Earliest trial started Jul 1, 1966 (NCT00003479)

Timeline

1960s

Jan 1, 1966
Earliest Phase 2 Sponsor(trial)

2010s

Jan 1, 2018
Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

UnclearUnclear
Unclear unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

atengenal
atengenal

Clinical trials

NCT ID	Phase	Start date	Sponsor(s)
NCT02887040	Phase 3	Jun 1, 2018	Burzynski Research Institute
NCT02864888	Phase 3	Jun 1, 2018	Burzynski Research Institute
NCT02742883	Phase 2	Apr 1, 2016	Burzynski Research Institute
NCT02988726	Phase 2	Mar 1, 1999	Burzynski Research Institute
NCT00003483	Phase 2	Jun 1, 1998	Burzynski Research Institute
NCT00003458	Phase 2	Sep 1, 1996	Burzynski Research Institute
NCT00003457	Phase 2	Jul 1, 1996	Burzynski Research Institute
NCT00003468	Phase 2	Jul 1, 1996	Burzynski Research Institute
NCT00003477	Phase 2	Jun 1, 1996	Burzynski Research Institute
NCT00003460	Phase 2	Apr 1, 1996	Burzynski Research Institute
NCT00003470	Phase 2	Mar 1, 1996	Burzynski Research Institute
NCT00003476	Phase 2	Mar 1, 1996	Burzynski Research Institute
NCT00003459	Phase 2	Mar 1, 1996	Burzynski Research Institute
NCT00003473	Phase 2	Mar 1, 1996	Burzynski Research Institute
NCT00003475	Phase 2	Feb 1, 1996	Burzynski Research Institute
NCT00003469	Phase 2	Feb 1, 1996	Burzynski Research Institute
NCT00003537	Phase 2	Apr 1, 1995	Burzynski Research Institute
NCT00003479	Phase 2	Jul 1, 1966	Burzynski Research Institute

Showing 18 of 18 trials

Page 1 / 1

Organizations

Research & Development (1)

Organization	Org type	Trials	As lead sponsor	Phases	Earliest year
Burzynski Research Institute	Academic/Hospital	18	18	2	1966

1 organizations

Page 1 / 1